Maximizing Patient Outcomes in Myelofibrosis: Stem Cell Transplantation in the JAK Inhibitor Era
View
26
Download
0
Category
Health & Medicine
Report
Preview:
Click to see full reader
Citation preview
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Page 63
Page 64
Page 65
Page 66
Page 67
Page 68
Page 69
Page 70
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Page 77
Page 78
Page 79
Page 80
Page 81
Recommended
SUPPLEMENTARY MATERIALS 1) Supplemental Methods · Dkk1 150 µg/mL 150 ng/mL Wnt GDC0941 100 mM 1 µM PI3K Jak Inhibitor I 10 mM 2 µM Jak family LDN193189 1 mM 2.5 µM BMP type 1
Documents
JAK type I cytokine receptor YYYYYY YYYYYY Y Y JAK kinase extracellular intracellular JAK-STAT signalling
Documents
CHRONIC MYELOPROLIFERATIVE NEOPLASMS · Spurious polycythemia ... myelodysplastic syndromes; PMF, primary myelofibrosis; PV, polycythemia ... Myelofibrosis is a chronic myeloproliferative
Documents
Unmet Needs in Myelofibrosis: Addressing Anemia
Documents
Case report myelofibrosis
Health & Medicine
EXTENDED REPORT The JAK inhibitor tofacitinib ...EXTENDED REPORT The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis D L Boyle,1 K Soma,2
Documents
RESEARCH Open Access Polyploidy in myelofibrosis: analysis
Documents
JAK-inhibitor and type I interferon ability to produce ... · RESEARCH ARTICLE Open Access JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19
Documents
EXTENDED REPORT The JAK inhibitor tofacitinib suppresses
Documents
The preclinical efficacy of a novel telomerase inhibitor, imetelstat ... · Baerlocher et al., NEJM 2015 • Imetelstat showed efficacy in myelofibrosis (complete or partial remission
Documents
Pivotal Data Highlights on Myeloproliferative Neoplasms Myelofibrosis
Documents
JOIST JAK SYSTEM SPECIFICATIONS Jak...Components Joist Jak™ System Components Joist Jak™ The Joist Jak™ is the main component of the Joist Jak™ deck system. Joist Jaks™ come
Documents
A multi-national open-label phase II study of the JAK inhibitor … · 2018-10-02 · A multi-national open-label phase II study of the JAK inhibitor INC424 in patients with primary
Documents
strategie školy na období · argumentovat a diskutovat, jak přijímat a odmítat, jak se nebát říci svůj názor, jak využívat volný þas, jak pochopit sám sebe, jak poznat
Documents
Small-Molecule Protein Kinases Inhibitors and the Risk of Fungal … · 2019. 12. 14. · Keywords Small-molecule protein kinases inhibitors . BTK inhibitor . mTOR inhibitor . JAK
Documents
Se Chang Kwon - hanmi.co.kr · (e.g., SYK, JAK) Next generation FLT3 Inhibitor overcoming resistance ... 2011 2012 2013 2014 2015 RAF inhibitor Exclusive Licensing WW ex. Korea Hyalrheuma
Documents
Erickson Rheuminations Final 2019 · Rheumatoid Arthritis • Tofacitinib • JAK inhibitor that is a oral small molecule • Increased risk of GI perforations • Decreased white
Documents
R&D Roundtable - AstraZeneca€¦ · Proprietary discovery across network of partners ... AZD4547 FGFR TKI. AZD1480 JAK 1, 2 inhibitor. AZD5363 AKT inhibitor. AZD5363. AKT inhibitor
Documents
Primary Myelofibrosis
Documents
i Development of Colon Targeting Tablet of a JAK Inhibitor
Documents